Mayne Pharma Group Limited

MAYNF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$59,839$110,068$101,714$96,672
Short-Term Investments$40,564$39,210$127,526$1,334
Receivables$164,619$193,222$194,887$268,241
Inventory$50,561$74,629$82,700$108,908
Other Curr. Assets$37,209$43,464$55,900$36,463
Total Curr. Assets$352,792$460,593$553,629$511,618
Property Plant & Equip (Net)$58,869$53,326$51,482$225,855
Goodwill$0$0$0$22,127
Intangibles$542,106$568,580$568,580$405,387
Long-Term Investments$0$15,337$0$0
Tax Assets$0$0$23,439$118,489
Other NC Assets$60,838$45,341$2,320$4,450
Total NC Assets$661,813$682,584$694,505$776,308
Other Assets$0$0$0$0
Total Assets$1,014,605$1,143,177$1,248,134$1,287,926
Liabilities
Payables$30,252$20,874$32,027$63,571
Short-Term Debt$38,616$35,461$14,427$407,993
Tax Payable$0$0$0$1,224
Deferred Revenue$0$6,536$7,651$121,144
Other Curr. Liab.$192,143$251,067$256,854$16,489
Total Curr. Liab.$261,011$313,938$310,959$610,421
LT Debt$2,655$35,001$33,078$5,673
Deferred Rev, NC$0$0$280$280
Deferred Tax Liab, NC$0$7,352$8,579$6,031
Other NC Liab.$380,656$332,698$261,158$108,681
Total NC Liab.$383,311$375,051$302,815$120,385
Other Liabilities$0$0$0$0
Cap. Leases$6,119$7,180$8,215$8,299
Total Liabilities$644,322$688,989$613,774$730,806
Equity
Pref Stock$0$0$0$0
Common Stock$1,225,979$1,224,224$1,233,692$1,238,537
Retained Earnings-$1,040,982-$944,003-$769,770-$822,406
AOCI$185,286$173,967$170,438$148,642
Other Equity$0$0$0$0
Total Equity$370,283$454,188$634,360$564,773
Supplemental Information
Minority Interest$0$0-$7,653-$7,653
Total Liab. & Tot. Equity$1,014,605$1,143,177$1,248,134$1,287,926
Net Debt-$18,568-$39,606-$54,209$316,994
Mayne Pharma Group Limited (MAYNF) Financial Statements & Key Stats | AlphaPilot